High Sensitivity Troponin for Contemporary Risk Stratification in Wild-Type ATTR Amyloidosis
- PMID: 40665892
- DOI: 10.1161/CIRCHEARTFAILURE.125.013129
High Sensitivity Troponin for Contemporary Risk Stratification in Wild-Type ATTR Amyloidosis
Keywords: Editorials; amyloid; biomarkers; heart failure; prognosis.
Conflict of interest statement
Dr Alexander has received consulting fees from Alnylam, Arbor Biotechnologies, Bayer, BridgeBio, Novo Nordisk, and Pfizer.
Comment on
-
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy.Circ Heart Fail. 2025 Aug;18(8):e012816. doi: 10.1161/CIRCHEARTFAILURE.125.012816. Epub 2025 May 15. Circ Heart Fail. 2025. PMID: 40371473 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
